Private equity firm Kohlberg & Company has acquired majority ownership of Amendia, and will support its growth initiatives from a US $1.6BB private equity fund.
Since 2015, Amendia has grown organically and through numerous M&A transactions, including Baxano assets, Custom Spine and SpineSelect. Within 2016 alone, product launches have included the OmegaLIF™ Expandable Interbody Cage and the inCORPorate PEEK Vertebral Body Replacement.
Amendia’s portfolio addresses spinal deformity, degeneration, minimally invasive and biologic solutions.
Sources: Amendia and ORTHOWORLD Inc.
Private equity firm Kohlberg & Company has acquired majority ownership of Amendia, and will support its growth initiatives from a US $1.6BB private equity fund.
Since 2015, Amendia has grown organically and through numerous M&A transactions, including Baxano assets, Custom Spine and SpineSelect. Within 2016 alone, product...
Private equity firm Kohlberg & Company has acquired majority ownership of Amendia, and will support its growth initiatives from a US $1.6BB private equity fund.
Since 2015, Amendia has grown organically and through numerous M&A transactions, including Baxano assets, Custom Spine and SpineSelect. Within 2016 alone, product launches have included the OmegaLIF™ Expandable Interbody Cage and the inCORPorate PEEK Vertebral Body Replacement.
Amendia’s portfolio addresses spinal deformity, degeneration, minimally invasive and biologic solutions.
Sources: Amendia and ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





